Danirixin (GSK1325756)是高亲和力的选择性CXCR2拮抗剂,抑制CXCL8 (IL-8)结合的IC50值为12.5 nM。 Product description: Danirixin is a selective, and reversible CXCR2 antagonist, with IC50 of 12.5 nM for CXCL8.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
danirixin
Dangerous GoodsCAS number:954126-98-8 molecular formula:C19H22Cl2FN3O4S
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | AKOS030527036 | SCHEMBL1198688 | GTPL8500 | HY-B1568 | UNII-R318PGH5VP | SPBio_002358 | MLS003899212 | EX-A1178 | GSK1325756B | GSK-1325756B | HY-19768 | AC-36168 | KBio1_000455 | GSK 1325756 | GSK1325756 | GSK-1325756 | DANIRIXIN [INN] | D10387 | Danirix | ||
| CAS number | 954126-98-8 | molecular formula | C19H22Cl2FN3O4S |
| molecular weight | 441.90 g/mol | Exact mass | - |
| PSA | 116.000 Ų | logp | 3.1 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
pictogram:
GHS08 , GHS07
Signal word:
Warning
Hazard Statement:
H373: 通过长时间或反复暴露对器官造成损害 H302: 吞食有害 H361: 怀疑破坏生育力或未出生的孩子
Statement of Preventive Measures:
P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P405: 密闭存放 P501: 将内容物/容器处理到。。。 P260: 不要吸入灰尘/烟雾/气体/雾/蒸汽/喷雾。 P203: 使用前,获取、阅读并遵守所有安全说明。 P318: 如果暴露或担心,请就医。 P319: 如果你感到不适,请寻求医疗帮助。
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





